𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral Disease-Modifying Therapies for Multiple Sclerosis: Are We There Yet?

✍ Scribed by Vijayshree Yadav; Dennis Bourdette

Publisher
Springer
Year
2010
Tongue
English
Weight
71 KB
Volume
10
Category
Article
ISSN
1528-4042

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nutritional therapy for alcoholic hepati
Nutritional therapy for alcoholic hepatitis: Are we there yet?
✍ Timothy R. Morgan; Charles L. Mendenhall πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 552 KB

just as the GS-positive hepatocytes are at the opposite end of the acinus. In conclusion, short-range cell-cell interactions between endothelial and mesenchymal cells of the portal triad or the central veins and the adjacent hepatocytes seem to play an important role in defining phenotypic characte

Innate origins of multiple sclerosis pat
Innate origins of multiple sclerosis pathogenesis: Implications for computer-assisted design of disease-modifying therapies
✍ Nicholas Stoy πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 519 KB

## Abstract The rational development of disease‐modifying therapies for multiple sclerosis (MS) requires a detailed knowledge of disease pathogenesis, but this remains incomplete. Dynamic computer‐assisted modeling of MS is currently hindered by uncertainties about the connectivity, compartmentaliz